Professional Overview
Shirine Shaar is a seasoned finance professional currently serving as the Finance Manager for Levant and Iraq at Roche. With a strong background in financial management and planning, her key expertise areas include financial analysis, pricing management, and team leadership, with a focus on the pharmaceutical industry.
Experience Summary
Current Role
As the Finance Manager at Roche, Shirine oversees financial operations across Levant and Iraq, driving business growth through strategic financial planning and management. Her key responsibilities include budgeting, forecasting, and financial reporting, alongside implementing pricing strategies to enhance profitability. Shirine's achievements in this role have significantly impacted the company's financial performance, although specific metrics are not available.
Career Progression
Shirine's career trajectory showcases progressive growth and expanding responsibilities. Notable previous roles include Financial Manager and Planning Manager at Eli Lilly and Company, where she managed financial operations and developed strategic plans for various regions, including the Near East Area, Iran, Iraq, Libya, Sudan, and others. Her career is marked by consistent promotions and increasing regional responsibilities, reflecting her exceptional performance and leadership capabilities.
Academic Background
Shirine holds an MBA in Finance from the American University of Beirut, completed between 1997 and 2000. This educational background has provided her with a solid foundation in financial principles, analysis, and management.
Areas of Expertise
Her industry-specific skills include financial planning, budgeting, and pricing strategy development, particularly within the pharmaceutical sector. Shirine also possesses technical competencies in financial analysis and reporting, alongside strong leadership and management capabilities, having led teams and managed projects across various regions.
Professional Impact
Although specific projects or initiatives are not detailed, Shirine's contributions to the pharmaceutical industry, through her roles at Roche and Eli Lilly, have been significant. Her ability to drive financial growth, implement effective pricing strategies, and lead cross-functional teams has made a measurable impact on the companies she has served.
Conclusion
Shirine Shaar's professional trajectory is marked by consistent growth, strategic vision, and leadership excellence. Currently focused on driving financial success at Roche, her value proposition lies in her ability to merge financial acumen with strategic planning, making her a valuable asset to any organization seeking to enhance its financial performance and operational efficiency.
